Diebold Nixdorf, Incorporated
DBD
$61.96
$0.210.34%
NYSE
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | 3.67B | 3.70B | 3.75B | 3.80B | 3.82B |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 3.67B | 3.70B | 3.75B | 3.80B | 3.82B |
Cost of Revenue | 2.74B | 2.76B | 2.80B | 2.86B | 2.91B |
Gross Profit | 934.10M | 935.40M | 947.80M | 936.20M | 906.50M |
SG&A Expenses | 572.20M | 568.90M | 568.80M | 572.80M | 558.80M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -2.60M | -4.50M | -3.80M | -200.00K | -200.00K |
Total Operating Expenses | 3.40B | 3.41B | 3.46B | 3.52B | 3.56B |
Operating Income | 276.80M | 282.90M | 293.80M | 274.50M | 259.70M |
Income Before Tax | 27.90M | 57.20M | 49.80M | 59.30M | 2.27B |
Income Tax Expenses | 38.00M | 65.20M | 64.30M | 57.30M | 108.30M |
Earnings from Continuing Operations | -10.10 | -8.00 | -14.50 | 2.00 | 2.17K |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -2.80M | -2.20M | -2.00M | -1.80M | -1.60M |
Net Income | -12.90M | -10.20M | -16.50M | 200.00K | 2.16B |
EBIT | 276.80M | 282.90M | 293.80M | 274.50M | 259.70M |
EBITDA | 415.00M | 420.10M | 430.40M | 409.10M | 399.40M |
EPS Basic | -0.34 | -0.27 | -0.44 | 0.01 | 38.21 |
Normalized Basic EPS | 2.14 | 2.54 | 2.70 | 2.68 | 1.91 |
EPS Diluted | -0.34 | -0.28 | -0.44 | 0.00 | 37.79 |
Normalized Diluted EPS | 2.14 | 2.54 | 2.70 | 2.67 | 1.90 |
Average Basic Shares Outstanding | 150.00M | 150.40M | 150.40M | 150.40M | 169.76M |
Average Diluted Shares Outstanding | 150.30M | 150.50M | 150.50M | 150.50M | 170.50M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |